Literature DB >> 6795637

Restricted reassociation of heavy and light chains from hapten-specific monoclonal antibodies.

D M Kranz, E W Voss.   

Abstract

Six murine monoclonal antifluorescyl antibody clones encompassing a defined range of affinities and containing kappa light chains with IgG1 or IgG2 heavy chains were examined. As the fluorescence of the ligand is quenched greater than 90% when fluorescein is bound by antifluorescyl antibodies, fluorescence quenching was assayed to monitor polypeptide reconstitution and active site formation on mixing of resolved heavy (H) and light (L) chains. Of 36 possible experimental combinations of H- and L-chain reaction mixtures, only homologous H and L chains (derived from the same parental immunoglobulin molecule) bound fluorescein. Results from fluorescence polarization studies, conducted independently of fluorescence quenching, confirmed the findings. Competitive inhibition and molecular sieve experiments showed that, despite preferential association of homologous H and L chains, several heterologous H and L chains associated to form intact 7S molecules, although no active site was constituted. Thus, polypeptide recombination and formation of functional antigen binding sites are two processes that immunocytes must regulate during cell differentiation and generation of diversity. A mechanism and underlying the observed preferential reassociation of specific H and L chains and a means of generating affinity maturation, as exhibited by the antifluorescein system, is proposed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795637      PMCID: PMC348870          DOI: 10.1073/pnas.78.9.5807

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  Fluorescein: a complete antigenic group.

Authors:  E W Voss; W Eschenfeldt; R T Root
Journal:  Immunochemistry       Date:  1976-05

3.  Mechanism of quenching of fluorescein by anti-fluorescein IgG antibodies.

Authors:  R M Watt; E W Voss
Journal:  Immunochemistry       Date:  1977-07

4.  Reconstitution from subunits of the hapten binding sites and idiotypic determinants of mouse anti-phosphorylcholine myeloma proteins.

Authors:  A Sher; E Lord; M Cohn
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

5.  Crystal properties as indicators of conformational changes during ligand binding or interconversion of Mcg light chain isomers.

Authors:  K R Ely; J R Firca; K J Williams; E E Abola; J M Fenton; M Schiffer; N C Panagiotopoulos; A B Edmundson
Journal:  Biochemistry       Date:  1978-01-10       Impact factor: 3.162

6.  Studies of 125I trace labeling of immunoglobulin G by chloramine-T.

Authors:  S Sonoda; M Schlamowitz
Journal:  Immunochemistry       Date:  1970-11

7.  Subunit interactions in mouse myeloma proteins with anti-galactan activity.

Authors:  B N Manjula; C P Glaudemans; E B Mushinski; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

8.  Specific interaction between VH and VL regions of human monoclonal immunoglobulins.

Authors:  C De Préval; M Fougereau
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

9.  Organization of immunoglobulin heavy chain genes and allelic deletion model.

Authors:  T Honjo; T Kataoka
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

10.  Specificity of recombination of H and L chains from human gamma-G-myeloma proteins.

Authors:  H M Grey; M Mannik
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  10 in total

1.  Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Authors:  Wolfgang Schaefer; Hans R Völger; Stefan Lorenz; Sabine Imhof-Jung; Jörg T Regula; Christian Klein; Michael Mølhøj
Journal:  MAbs       Date:  2015-10-23       Impact factor: 5.857

2.  Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.

Authors:  A S Kang; T M Jones; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

4.  Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.

Authors:  Bryan D Choi; Patrick C Gedeon; Chien-Tsun Kuan; Luis Sanchez-Perez; Gary E Archer; Darell D Bigner; John H Sampson
Journal:  J Immunol Methods       Date:  2013-06-24       Impact factor: 2.303

5.  The VKIIIb light chain sub-subgroup: restricted association with mu heavy chain in normal human serum.

Authors:  J A Moynihan; R J Looney; G N Abraham
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

6.  Fourteen nucleotides in the second complementarity-determining region of a human heavy-chain variable region gene are identical with a sequence in a human D minigene.

Authors:  T T Wu; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Authors:  Adnan Memic; Veronica V Volgina; Hélène A Gussin; David R Pepperberg; Brian K Kay
Journal:  J Immunol Methods       Date:  2011-02-26       Impact factor: 2.303

8.  Frequency of expressed immunoglobulin light chain genes in lipopolysaccharide-stimulated BALB/c spleen cells.

Authors:  D Zhu; I Lefkovits; G Köhler
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.

Authors:  C Chen; T M Martin; S Stevens; M B Rittenberg
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  Receptor editing: an approach by autoreactive B cells to escape tolerance.

Authors:  D Gay; T Saunders; S Camper; M Weigert
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.